COPD - Nationale VersorgungsLeitlinien

255. Rice KL, Leatherman JW, Duane PG, Snyder LS, Harmon KR, Abel J, Niewoehner DE.
Aminophylline for acute exacerbations of chronic obstructive pulmonary disease. A controlled trial.
Ann Intern Med 1987;107(3):305-9.
256. Gillissen A, Buhl R, Kardos P, Kenn K, Matthys H, Pfister R, Rabe KF, Sauer R, Vogelmeier C,
Wettengel R, Worth H, Menz G. Management der akuten Exazerbation der chronisch-obstruktiven
Lungenerkrankung (COPD). Dtsch Med Wochenschr 2003;128(33):1721-7.
257. Niewoehner DE, Erbland ML, Deupree RH, Collins D, Gross NJ, Light RW, Anderson P, Morgan NA.
Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease.
Department of Veterans Affairs Cooperative Study Group. N Engl J Med 1999;340(25):1941-7.
258. Davies L, Angus RM, Calverley PM. Oral corticosteroids in patients admitted to hospital with
exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial.
Lancet 1999;354(9177):456-60.
259. Thompson WH, Nielson CP, Carvalho P, Charan NB, Crowley JJ. Controlled trial of oral prednisone
in outpatients with acute COPD exacerbation. Am J Respir Crit Care Med 1996;154(2 Pt 1):407-12.
260. Wood-Baker RR, Gibson PG, Hannay M, Walters EH, Walters JA. Systemic corticosteroids for acute
exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev
2005;(1):CD001288.
261. Eller J, Ede A, Schaberg T, Niederman MS, Mauch H, Lode H. Infective exacerbations of chronic
bronchitis: relation between bacteriologic etiology and lung function. Chest 1998;113(6):1542-8.
262. Vogel A, Worth H, Adam D. Rationale Therapie bakterieller Atemwegsinfektionen. Empfehlungen
einer Expertengruppe der Paul-Ehrlich-Gesellschaft für Chemotherapie e. V. und der Deutschen
Atemwegsliga e. V. Chemother J 2000;9(1):3-23.
263. Paul-Ehrlich-Gesellschaft für Chemotherapie, Deutsche Gesellschaft für Pneumologie, Deutsche
Gesellschaft für Infektiologie, Kompetenzwerk CAPNETZ. Epidemiologie, Diagnostik, antimikrobielle
Therapie und Management von erwachsenen Patienten mit ambulant erworbenen tiefen
Atemwegsinfektionen (akute Bronchitis, akute Exazerbation einer chronischen Bronchitis, Influenza
und andere respiratorische Virusinfektionen) sowie ambulant erworbener Pneumonie. 2005 [cited:
2006 Jan 27]. Available from: http://www.uni-duesseldorf.de/AWMF/ll/082-001.htm
264. Rossi A, Gottfried SB, Higgs BD, Zocchi L, Grassino A, Milic-Emili J. Respiratory mechanics in
mechanically ventilated patients with respiratory failure. J Appl Physiol 1985;58(6):1849-58.
265. Georgopoulos D, Rossi A, Moxham J. Ventilatory support in chronic obstructive pulmonary disease.
Eur Respir Mon 1998;7:189-208.
266. Plant PK, Owen JL, Elliott MW. Early use of non-invasive ventilation for acute exacerbations of
chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomised
controlled trial. Lancet 2000;355(9219):1931-5.
267. Barbe F, Togores B, Rubi M, Pons S, Maimo A, Agusti AG. Noninvasive ventilatory support does not
facilitate recovery from acute respiratory failure in chronic obstructive pulmonary disease. Eur Respir
J 1996;9(6):1240-5.
268. Kramer N, Meyer TJ, Meharg J, Cece RD, Hill NS. Randomized, prospective trial of noninvasive
positive pressure ventilation in acute respiratory failure. Am J Respir Crit Care Med
1995;151(6):1799-806.
269. Brochard L, Mancebo J, Wysocki M, Lofaso F, Conti G, Rauss A, Simonneau G, Benito S,
Gasparetto A, Lemaire F. Noninvasive ventilation for acute exacerbations of chronic obstructive
pulmonary disease. N Engl J Med 1995;333(13):817-22.
© 2006
94